Bovine somatotropin or bovine somatotrophin (abbreviated bST and BST), or BGH, is a peptide hormone produced by cows’ pituitary gland. Like other hormones, it is produced in small quantities and is used in regulating metabolic processes. After the biotech company Genentech discovered and patented the gene for BST in the 1970s, it became possible to synthesize the hormone using recombinant DNA technology to create recombinant bovine somatotropin (rBST), recombinant bovine growth hormone (rBGH), or artificial growth hormone. Four large pharmaceutical companies, Monsanto, American Cyanamid, Eli Lilly, and Upjohn, developed commercial rBST products and submitted them to the US Food and Drug Administration (FDA) for approval. Monsanto was the first firm to receive approval. Other countries (Mexico, Brazil, India, Russia and at least ten others) also approved rBST for commercial use. Monsanto licensed Genentech’s patent, and marketed their product as “Posilac”. In October 2008, Monsanto sold this business, in full, to Eli Lilly and Company for $300 million plus additional consideration.
rBST has not been allowed on the market in Canada, Australia, New Zealand, Japan, Israel and all European Union countries (currently numbering 27), by 2000 or earlier.
RBGH is a synthetic version of natural bovine somatotropin (BST). It’s injected into cows to increase milk production, but it is banned in at least 30 other nations because of its dangers to human health, which include an increased risk for colorectal, prostate, and breast cancer by promoting conversion of normal tissue cells into cancerous ones. The only way to avoid rBGH is to look for products labeled as “rBGH-free” or “No rBGH.” RBGH is banned in Australia, New Zealand, Israel, the EU, and Canada.
What, you want to drink puss with your milk? Or feed this to your children? If so, knock yourself out.